Recent Finacing
Recent Raise
Monument Therapeutics uses proprietary digital cognitive assessments and biomarkers to stratify CNS trial patients and develop therapies for cognitive impairment in schizophrenia and neuroinflammation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Cambridge Cognition.
